Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23848-46-6

Post Buying Request

23848-46-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23848-46-6 Usage

Description

5beta-Cholan-3alpha,7alpha,24-triol, also known as Chenodeoxycholan-24-ol, is a naturally occurring intermediate compound in the synthesis of bile acids. It plays a crucial role in the side chain oxidation process during the production of bile acids, which are essential for the digestion and absorption of dietary fats.

Uses

Used in Pharmaceutical Industry:
5beta-Cholan-3alpha,7alpha,24-triol is used as an intermediate in the synthesis of 3α,7α-Dihydroxycoprostanic Acid-d3 (D452517), a labelled analogue of 3α,7α-Dihydroxycoprostanic Acid (D452515). This analogue serves as a precursor to Cholic Acid (C432600), which is a vital component in the production of bile acids. The compound is particularly relevant in the study and treatment of Zellweger's syndrome, a rare genetic disorder characterized by abnormal mitochondrial structure and impaired side chain oxidation, leading to an accumulation of 3α,7α-Dihydroxycoprostanic Acid.
In the context of Zellweger's syndrome research and treatment, 5beta-Cholan-3alpha,7alpha,24-triol is used as a diagnostic marker for the condition. The abnormal accumulation of 3α,7α-Dihydroxycoprostanic Acid in patients with this syndrome can be attributed to the impaired mitochondrial function, which is essential for the side chain oxidation of bile acid precursors. 5beta-Cholan-3alpha,7alpha,24-triol can help researchers understand the underlying mechanisms of the disease and potentially contribute to the development of targeted therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 23848-46-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,8,4 and 8 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 23848-46:
(7*2)+(6*3)+(5*8)+(4*4)+(3*8)+(2*4)+(1*6)=126
126 % 10 = 6
So 23848-46-6 is a valid CAS Registry Number.

23848-46-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3α,7α-dihydroxy-5β-cholan-24-ol

1.2 Other means of identification

Product number -
Other names 3α,7α,24-trihydroxy-5β-cholane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23848-46-6 SDS

23848-46-6Relevant articles and documents

Specific Interactions between Sodium Deoxycholate and its Water-Insoluble Analogues. Mechanisms for Premicelle and Micelle Formation of Sodium Deoxycholate

Kano, Koji,Tatemoto, Shinichi,Hashimoto, Shizunobu

, p. 966 - 970 (1991)

Interactions between sodium deoxycholate (NaDC, host) and its water-insoluble analogues (guests) have been studied in water (pH 10) to clarify the mechanisms for the premicelle and micelle formation of NaDC.Turbidity measurements have been used as a convenient method to study the interactions between the guest and host molecules.At least two α-hydroxy groups attached to the C-3 and C-12 positions of a steroid nucleus are required for the guest steroids to interact with NaDC below the critical micelle concentration.This strongly suggests the formation of a hydrogen-bonded dimer of NaDC as a premicelle whose formation is assisted by the hydrophobic environment provided by the α-plane of the steroid.The guest steroids having a hydroxy group at the C-3 position and a polar head group at the C-24 position, which can participate in hydrogen bonding, are solubilized by the NaDC micelles.The results support the mechanism for the NaDC micelle formation involving hydrogen bonding between the C-3 hydroxy group of a premicelle and the C-24 carboxylate anion of another premicelle.

Rapid Deoxyfluorination of Alcohols with N-Tosyl-4-chlorobenzenesulfonimidoyl Fluoride (SulfoxFluor) at Room Temperature

Guo, Junkai,Kuang, Cuiwen,Rong, Jian,Li, Lingchun,Ni, Chuanfa,Hu, Jinbo

supporting information, p. 7259 - 7264 (2019/05/10)

The deoxyfluorination of alcohols is a fundamentally important approach to access alkyl fluorides, and thus the development of shelf-stable, easy-to-handle, fluorine-economical, and highly selective deoxyfluorination reagents is highly desired. This work describes the development of a crystalline compound, N-tosyl-4-chlorobenzenesulfonimidoyl fluoride (SulfoxFluor), as a novel deoxyfluorination reagent that possesses all of the aforementioned merits, which is rare in the arena of deoxyfluorination. Endowed by the multi-dimensional modulating ability of the sulfonimidoyl group, SulfoxFluor is superior to 2-pyridinesulfonyl fluoride (PyFluor) in fluorination rate, and is also superior to perfluorobutanesulfonyl fluoride (PBSF) in fluorine-economy. Its reaction with alcohols not only tolerates a wide range of functionalities including the more sterically hindered alcoholic hydroxyl groups, but also exhibits high fluorination/elimination selectivity. Because SulfoxFluor can be easily prepared from inexpensive materials and can be safely handled without special techniques, it promises to serve as a practical deoxyfluorination reagent for the synthesis of various alkyl fluorides.

Modification on ursodeoxycholic acid (UDCA) scaffold. Discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1)

Sepe, Valentina,Renga, Barbara,Festa, Carmen,Damore, Claudio,Masullo, Dario,Cipriani, Sabrina,Di Leva, Francesco Saverio,Monti, Maria Chiara,Novellino, Ettore,Limongelli, Vittorio,Zampella, Angela,Fiorucci, Stefano

, p. 7687 - 7701 (2014/12/12)

Bile acids are signaling molecules interacting with the nuclear receptor FXR and the G-protein coupled receptor 1 (GP-BAR1/TGR5). GP-BAR1 is a promising pharmacological target for the treatment of steatohepatitis, type 2 diabetes, and obesity. Endogenous bile acids and currently available semisynthetic bile acids are poorly selective toward GP-BAR1 and FXR. Thus, in the present study we have investigated around the structure of UDCA, a clinically used bile acid devoid of FXR agonist activity, to develop a large family of side chain modified 3,7 dihydroxyl cholanoids that selectively activate GP-BAR1. In vivo and in vitro pharmacological evaluation demonstrated that administration of compound 16 selectively increases the expression of pro-glucagon 1, a GP-BAR1 target, in the small intestine, while it had no effect on FXR target genes in the liver. Further, compound 16 results in a significant reshaping of bile acid pool in a rodent model of cholestasis. These data demonstrate that UDCA is a useful scaffold to generate novel and selective steroidal ligands for GP-BAR1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23848-46-6